Immunology Market research report by Delvens focuses on primary sections such as – market segments, market outlook, competitive landscape, and company profiles. The segments provide details in terms of various perspectives such as end-use industry, product or service type, and any other relevant segmentation as per the market’s current scenario which includes various aspects to perform further marketing activity, the global Immunology Market size is projected to reach a CAGR of 8.1% from 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/immunology-market
The growth of the market can be attributed to various factors such as the Increasing prevalence of autoimmune disorders and increasing product approvals by regulatory agencies. Furthermore, increasing funding from various government and non-government organizations is also an important factor responsible for the growth of the market.
On the other hand, the high costs of immunology drugs, adverse effects associated with these drugs, and lack of awareness are the major factors that can hinder the growth of the global immunology market.
The prominent players in Immunology Market are
· AbbVie Inc.
· Janssen Global Services
· Johnson & Johnson
· F. Hoffmann-La Roche Ltd
· Amgen Inc.
· Pfizer Inc.
· Novartis
· Astellas
· Bristol-Myers Squibb Company
· Merck Sharp & Dohme Corp.
· UCB SA
· Allergan plc
Immunology Market is segmented into various segments such as drug class, disease indication, distribution channel, and region:
On the basis of the drug class
· Monoclonal Antibody (mAb)
· Fusion Proteins
· Immunosuppressants
· Polyclonal Antibody (pAb)
· Others
Based on disease indication
· Rheumatoid Arthritis
· Psoriatic Arthritis
· Plaque Psoriasis
· Ankylosing Spondylitis
· Inflammatory Bowel Disease
· Prophylaxis of Organ Rejection
· Others
Based on the distribution channel
· Hospital Pharmacies
· Retail Pharmacies
· Online Pharmacies
Based on region
· Asia Pacific
· North America
· Europe
· South America
· Middle East & Africa
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/immunology-market
The factor responsible for the growth of the global immunology market is the increased funding from various government and non-government organizations. This funding is crucial in ensuring that the necessary resources are available for research and development, as well as for the production and distribution of immunology drugs. On the other hand, the high costs of immunology drugs can be a major obstacle to the growth of the market.
Additionally, the adverse effects associated with these drugs can also limit their usage, especially in patients who have other underlying medical conditions. Furthermore, the lack of awareness about the benefits of immunology drugs can also hinder their uptake and limit market growth. It is therefore essential to continue investing in research and development to improve the safety and efficacy of immunology drugs, as well as to increase public awareness about their potential benefits.
North America to Dominate the Market
North America has the largest share in the immunology drug market because of the availability of better reimbursement policies, the high potential to invest a huge amount of money in the development of immunology drugs, and due to the advancement of technologies.
Recent Developments
August 29, 2022 - AbbVie Showcases New Analyses and Real-World Data Across Multiple Immune-Mediated Skin Diseases at the European Academy of Dermatology and Venereology (EADV).
August 24, 2022 - AbbVie announced that the U.S. Food and Drug Administration (FDA) approved the use of IMBRUVICA® (ibrutinib) for the treatment of pediatric patients one year and older with chronic graft versus host disease (cGVHD) after the failure of one or more lines of systemic therapy.
Access Full Report: https://www.delvens.com/report/immunology-market
In addition to the market data for Immunology Market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement.
Reasons to Acquire
· Increase your understanding of the market for identifying the best and most suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
· Gain authentic and granular data access for Immunology Market to understand the trends and the factors involved in changing market situations.
· Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
· In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek